Biomarkers in Lone Atrial Fibrillation-An Additional ‘Fine Tuning’ of Risk?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|5|646-658

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.5, 2015-02, pp. : 646-658

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lone Atrial Fibrillation- A Diagnosis of Exclusion

By  

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 544-550

Bentham Science Publishers

Access to resources Recommend Favorite

Catheter Ablation of Lone Atrial Fibrillation

By  

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 591-612

Bentham Science Publishers

Access to resources Recommend Favorite

Lone Atrial Fibrillation: Electrophysiology, Risk Factors, Catheter Ablation and Other Non-pharmacologic Treatments

By  

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 580-590

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’

By  

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 573-579

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelial (Dys)Function in Lone Atrial Fibrillation

By  

Current Pharmaceutical Design, Vol. 21, Iss. 5, 2015-02 ,pp. : 622-645

Bentham Science Publishers

Access to resources Recommend Favorite